We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Respiratory Viruses Detected by Sensitive Molecular Technique

By LabMedica International staff writers
Posted on 15 Oct 2014
The diagnosis of respiratory viruses is presently based on virus isolation, detection of antigens, or serology—all of which are too time-consuming and, in some cases, have low sensitivity.

A real-time reverse transcriptase polymerase chain reaction (RT-PCR) detection method has been used to determine the frequency of a wide range of respiratory viruses in specimens from outpatients of all ages with acute respiratory infection (ARI). More...


Virologists at the Universidade Federal do Espírito Santo (Vitória, Brazil) collected nasopharyngeal aspirates (NPAs) from 162 patients of all ages who were attended at either emergency rooms or primary care units between August 2007 and August 2009. All samples were tested by indirect immunofluorescence assay (IIF) and Fast-Track Diagnostics Respiratory Pathogens 21 PLUS (FTDRP) multiplex real-time RT-PCR assay. Twenty-three respiratory pathogens, including 18 human respiratory viruses and 5 bacterial species, were tested using the multiplex protocol.

Seven respiratory viruses, respiratory syncytial virus (RSV), parainfluenza viruses 1-3 (PIV 1-3), influenza viruses A and B (Inf A, Inf B) and human adenovirus (HAdV) were screened in all specimens by IIF using the Respiratory Panel 1 Viral Screening & Identification Kit (Chemicon International, Millipore; Billerica, MA, USA). Multiplex real-time RT-PCR was performed using the FTDRP 21 plus (Fast-track Diagnostics; Sliema, Malta). Amplification was performed in the ABI 7500 real-time PCR system thermocycler (Applied Biosystems; Foster City, CA, USA).

The IIF method detected 33 positive specimens (20.4%) with the influenza virus the most common etiologic agent detected (23/33). Inf A and Inf B corresponded to 8% (13/162) and 6.2% (10/162) of the samples, respectively, and the IIF technique detected only single infections. The investigators reported that 88 (54.3%) specimens were positive for one or more respiratory viruses by multiplex real-time RT-PCR. The influenza virus (15.4%), human rhinovirus (HRV) (8%) and RSV (7.4%) were the viruses most frequently detected and accounted for one-third of the positive samples. Six cases of viral co-detection were observed, mainly involving RSV. The following bacteria were detected: Streptococcus pneumoniae in 43 samples, Staphylococcus aureus in 20, and 2 with Haemophilus influenza.

The authors concluded that the use of multiplex real-time RT-PCR increased the viral detection by 33.9% and revealed a larger number of respiratory viruses implicated in ARI cases, including the most recently described respiratory viruses, human bocavirus, Human metapneumovirus, influenza A (H1N1) pdm09 virus, Human coronavirus NL63 (HCoV) and HCoV HKU1. The study was published in the September 2014 issue of the Memorias do Instituto Oswaldo Cruz.

Related Links:

Universidade Federal do Espírito Santo
Chemicon International 
Fast-track Diagnostics



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Blood Glucose Reference Analyzer
Nova Primary
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.